PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LMAT vs. ZBH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LMAT and ZBH is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

LMAT vs. ZBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
19.01%
1.50%
LMAT
ZBH

Key characteristics

Sharpe Ratio

LMAT:

1.92

ZBH:

-0.61

Sortino Ratio

LMAT:

2.80

ZBH:

-0.73

Omega Ratio

LMAT:

1.36

ZBH:

0.91

Calmar Ratio

LMAT:

4.03

ZBH:

-0.33

Martin Ratio

LMAT:

10.54

ZBH:

-0.86

Ulcer Index

LMAT:

6.23%

ZBH:

15.34%

Daily Std Dev

LMAT:

34.28%

ZBH:

21.64%

Max Drawdown

LMAT:

-75.69%

ZBH:

-65.03%

Current Drawdown

LMAT:

-11.61%

ZBH:

-35.71%

Fundamentals

Market Cap

LMAT:

$2.18B

ZBH:

$21.79B

EPS

LMAT:

$1.82

ZBH:

$5.24

PE Ratio

LMAT:

53.26

ZBH:

20.89

PEG Ratio

LMAT:

2.20

ZBH:

1.44

Total Revenue (TTM)

LMAT:

$164.15M

ZBH:

$5.66B

Gross Profit (TTM)

LMAT:

$110.84M

ZBH:

$3.63B

EBITDA (TTM)

LMAT:

$46.59M

ZBH:

$1.81B

Returns By Period

In the year-to-date period, LMAT achieves a 3.57% return, which is significantly higher than ZBH's 2.40% return. Over the past 10 years, LMAT has outperformed ZBH with an annualized return of 30.10%, while ZBH has yielded a comparatively lower 0.39% annualized return.


LMAT

YTD

3.57%

1M

4.02%

6M

19.01%

1Y

63.87%

5Y*

22.42%

10Y*

30.10%

ZBH

YTD

2.40%

1M

3.53%

6M

1.50%

1Y

-13.64%

5Y*

-5.99%

10Y*

0.39%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LMAT vs. ZBH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LMAT
The Risk-Adjusted Performance Rank of LMAT is 9292
Overall Rank
The Sharpe Ratio Rank of LMAT is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of LMAT is 9090
Sortino Ratio Rank
The Omega Ratio Rank of LMAT is 8989
Omega Ratio Rank
The Calmar Ratio Rank of LMAT is 9797
Calmar Ratio Rank
The Martin Ratio Rank of LMAT is 9393
Martin Ratio Rank

ZBH
The Risk-Adjusted Performance Rank of ZBH is 2020
Overall Rank
The Sharpe Ratio Rank of ZBH is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of ZBH is 1515
Sortino Ratio Rank
The Omega Ratio Rank of ZBH is 1616
Omega Ratio Rank
The Calmar Ratio Rank of ZBH is 2727
Calmar Ratio Rank
The Martin Ratio Rank of ZBH is 2727
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LMAT vs. ZBH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and Zimmer Biomet Holdings, Inc. (ZBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LMAT, currently valued at 1.92, compared to the broader market-2.000.002.001.92-0.61
The chart of Sortino ratio for LMAT, currently valued at 2.80, compared to the broader market-4.00-2.000.002.004.002.80-0.73
The chart of Omega ratio for LMAT, currently valued at 1.36, compared to the broader market0.501.001.502.001.360.91
The chart of Calmar ratio for LMAT, currently valued at 4.03, compared to the broader market0.002.004.006.004.03-0.33
The chart of Martin ratio for LMAT, currently valued at 10.54, compared to the broader market-10.000.0010.0020.0030.0010.54-0.86
LMAT
ZBH

The current LMAT Sharpe Ratio is 1.92, which is higher than the ZBH Sharpe Ratio of -0.61. The chart below compares the historical Sharpe Ratios of LMAT and ZBH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
1.92
-0.61
LMAT
ZBH

Dividends

LMAT vs. ZBH - Dividend Comparison

LMAT's dividend yield for the trailing twelve months is around 0.67%, less than ZBH's 0.89% yield.


TTM20242023202220212020201920182017201620152014
LMAT
LeMaitre Vascular, Inc.
0.67%0.69%0.99%1.09%0.88%0.94%0.95%1.18%0.69%0.71%0.93%1.83%
ZBH
Zimmer Biomet Holdings, Inc.
0.89%0.91%0.79%0.75%0.76%0.62%0.64%0.93%0.80%0.93%0.86%0.78%

Drawdowns

LMAT vs. ZBH - Drawdown Comparison

The maximum LMAT drawdown since its inception was -75.69%, which is greater than ZBH's maximum drawdown of -65.03%. Use the drawdown chart below to compare losses from any high point for LMAT and ZBH. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-11.61%
-35.71%
LMAT
ZBH

Volatility

LMAT vs. ZBH - Volatility Comparison

LeMaitre Vascular, Inc. (LMAT) has a higher volatility of 6.71% compared to Zimmer Biomet Holdings, Inc. (ZBH) at 5.73%. This indicates that LMAT's price experiences larger fluctuations and is considered to be riskier than ZBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%SeptemberOctoberNovemberDecember2025February
6.71%
5.73%
LMAT
ZBH

Financials

LMAT vs. ZBH - Financials Comparison

This section allows you to compare key financial metrics between LeMaitre Vascular, Inc. and Zimmer Biomet Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab